UK start-up, EveryBaby has appointed Angela Spang as its new CEO with the aim of getting this point-of-care instrument to professionals as quickly as possible.
EveryBaby is an innovative preterm diagnostic device that uses impedance spectroscopy to identify changes in cervical tissue when a mother is approaching birth. It provides real-time information that is more accurate than traditional methods such as transvaginal ultrasound or fetal fibronectin tests at a fraction of their usual costs.
Angela Spang brings over 20 years of experience in the biomedical sector to the role. She founded the medical device company, June Medical which received a Queen’s Award for Enterprise for Innovation in 2021. This success led to Angela being named UK CEO of the year in 2021 by Corporate Today. Her experience will be crucial for the success of EveryBaby’s new device and will facilitate the development and adoption of this novel diagnostic method.
EveryBaby innovation
Angela said: “I am delighted and humbled to join the dynamic team at EveryBaby. I was shocked to read how many preterm births there are each year and the resulting chronic health concerns for babies.
EveryBaby can really help to change this, improving access to safe, accurate and cost-effective diagnostics for better management of pregnancies and the prevention of avoidable preterm births all around the world.”
Read more: Study suggests best time for battling symptoms is during perimenopause
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.
